Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001228684-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 17, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
12,902
Total Value
$979,744.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 201 | โ | โ | 106,987 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 11,675 | $78.33 | $914,502.75 | 95,312 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 759 | $79.00 | $59,961.00 | 94,553 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 15, 2026 | Sale | 66 | $80.01 | $5,280.66 | 94,487 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Sep 15, 2026 | Exercise/Conversion | 201 | $0.00 | $0.00 | 605 | Direct | โ | View Details |